Mass spectrometry-based proteomics in reproductive medicine

Mass Spectrometry Reviews

Volumn 27, Issue 6, 2008, Pages 624-634

  Kolialexi, Aggeliki ^a   Mavrou, Ariadni ^a   Spyrou, George ^b   Tsangaris, George Th ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Amniotic fluid; Cervical vaginal fluid; Follicular fluid; Proteomics; Reproduction

Indexed keywords

ECOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; MEDICINE; MOLECULAR BIOLOGY; OBSTETRICS; PROTEINS; SPECTROMETERS; SPECTROMETRY; SPECTRUM ANALYSIS;

AMNIOTIC FLUID; CERVICAL VAGINAL FLUID; FOLLICULAR FLUID; PROTEOMICS; REPRODUCTION;

FLUIDS;

PROTEOME;

ARTICLE; FEMALE; FEMALE GENITAL SYSTEM; GENE EXPRESSION PROFILING; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; PREGNANCY; PROTEOMICS; REPRODUCTION;

FEMALE; GENE EXPRESSION PROFILING; GENITALIA, FEMALE; HUMANS; MASS SPECTROMETRY; PREGNANCY; PROTEOME; PROTEOMICS; REPRODUCTIVE MEDICINE;

EID: 57249100563     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/mas.20181     Document Type: Article

References (88)

1. Anahory T, Dechaud H, Bennes R, Marin P, Lamb NJ, Laoudj D. 2002. Identification of new proteins in follicular fluid of mature human follicles. Electrophoresis 23:1197-11202.
2. Angelucci S, Ciavardelli D, Di Giuseppe F, Eleuterio E, Sulpizio M, Tiboni GM, Giampietro F, Palumbo P, Di Ilio C. 2006. Proteome analysis of human follicular fluid. Biochim Biophys Acta 1764:1775-1785.
3. Atwood JA III, Sahoo SS, Alvarez-Manilla G, Weatherly DB, Kolli K, Orlando R, York WS. 2005. Simple modification of a protein database for mass spectral identification of N-linked glycopeptides. Rapid Commun Mass Spectrom 19:3002-3006.
4. Bigelow JL, Dunson DB, Stanford JB, Ecochard R, Gnoth C, Colombo B. 2004. Mucus observations in the fertile window: A better predictor of conception than timing of intercourse. Hum Reprod 19:889-892.
5. Blanco JD. 2000. Clinical problem of preterm labor. Clin Obstet Gynecol 43:713-716.
6. Brewis IA. 1999. Proteomics in reproductive research: The potential importance of proteomics to research in reproduction. Hum Reprod 14:2927-2929.
7. Buhimschi IA, Christner R, Buhimschi CS. 2005a. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. Br J Obstet Gynaecol 112:173-181.
8. Buhimschi IA, Buhimschi CS, Christner R, Weiner CP. 2005b. Proteomics technology for the accurate diagnosis of inflammation in twin pregnancies. Br J Obstet Gynaecol 112:250-255.
9. Buhimschi CS, Weiner CP, Buhimschi IA. 2006. Proteomics. Part II. The emerging role of proteomics over genomics in spontaneous preterm labor/birth. Obstet Gynecol. Survey 61:543-553.
10. Buhimschi CS, Buhimschi IA, Abdel-Razeq S, Rosenberg VA, Thung SF, Zhao G, Wang E, Bhandari V. 2007. Proteomic biomarkers of intra-amniotic inflammation: Relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res 61:318-324.
11. Butt RH, Lee MW, Pirshahid SA, Backlund PS, Wood S, Coorssen JR. 2006. An initial proteomic analysis of human preterm labor: Placental membranes. J Proteome Res 5:3161-3372.
12. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M. 2000. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 105:577-587.
13. Cole AM. 2006. Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol 306:199-230.
14. Chiu PC, Ho PC, Ng EH, Yeung WS. 2002. Comparative study of the biological activity of spermatozoa-zona pellucida binding inhibitory factors from human follicular fluid on various sperm function parameters. Mol Reprod Dev 61:205-212.
15. Cho CK, Shan SJ, Winsor EJ, Diamandis EP. 2007. Proteomics analysis of human amniotic fluid. Mol. Cell Proteomics 6:1406-1415.
16. Dasari S, Pereira L, Reddy AP, Michaels JE, Lu X, Jacob T, Thomas A, Rodland M, Roberts CT Jr, Gravett MG, Nagalla SR. 2007. Comprehensive proteomic analysis of human cervical-vaginal fluid. J Proteome Res 6:1258-1268.
17. Dekker GA. 1999. Risk factors for preeclampsia. Clin Obstet Gynecol 42:422-435.
18. Di Quinzio MK, Oliva K, Holdsworth SJ, Ayhan M, Walker SP, Rice GE, Georgiou HM, Permezel M. 2007. Proteomic analysis and characterisation of human cervico-vaginal fluid proteins. Aust NZ J Obstet Gynaecol 147:9-15.
19. Durand G, Seta N. 2000. Protein glycosylation and diseases: Blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin Chem. 46:795-805.
20. Eriksen GV, Carlstedt I, Morgelin M, Uldbjerg N, Malmstrom. A. 1999. Isolation and characterization of proteoglycans from human follicular fluid. Biochem J 340:613-620.
21. Fortunato SJ, Menon R. 2001. Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes. Am J Obstet Gynecol 184:1399-1405.
22. Fortune JE. 1994. Ovarian follicular growth and development in mammals. Biol Reprod 1994. 50:225-232.
23. Fountoulakis M, Langen H. 1997. Ligand-independent dimerization of the extracellular domain of the leptin receptor and determination of the stoichiometry of leptin binding. Anal Biochem. 250:153-156.
24. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. 1997. Regulation of human placental development by oxygen tension. Science 12(5332):1669-1672.
25. Götting C, Kuhn J, Tinneberg HR, Brinkmann T, Kleesiek K. 2002. High xylosyltransferase activities in human follicular fluid and cultured granulosa-lutein cells. Mol Hum Reprod 8:1079-1086.
26. Gravett MG, Hummel D, Eschenbach DA, Holmes KK. 1986. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 67:229-237.
27. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, McCor-mack A, Lapidus JA, Hitti J, Eschenbach DA, Roberts CT Jr, Nagalla SR. 2004. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel bio-markers. J Am Med Assoc 28:462-469.
28. Hanrieder J, Nyakas A, Naessén T, Bergquist J. 2008. Proteomic analysis of human follicular fluid using an alternative bottom-up approach. J Proteome Res 4:443-449.
29. Helmig BR, Romero R, Espinoza J, Chaiworapongsa T, Bujold E, Gomez R, Ohlsson K, Uldbjerg N. 2002. Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. Matern Fetal Neonatal. Med 12:237-246.
30. Hitti J, Watts DH, Burchett SK, Schacker T, Selke S, Brown ZA, Corey L. 1997. Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol 177:450-454.
31. Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ. 2001. Functional proteomics: Examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 3:4077-4086.
32. Huggins GR, Preti G. 1981. Vaginal odors and secretions. Clin Obstet Gynecol 24:355-377.
33. Irving-Rodgers HF, Rodgers RJ. 2006. Extracellular matrix of the corpus luteum. Semin Reprod Med 24:195-203.
34. Jauniaux E, Jurkovic D, Gulbis B, Gervy C, Ooms HA, Campbell S. 1991. Bio-chemical composition of exocoelomic fluid in early human pregnancy. Obstet Gynecol 78:1124-1128.
35. Jauniaux E, Jurkovic D, Gulbis B, Collins WP, Zaidi J, Campbell S. 1994. Investigation of the acid-base balance of coelomic and amniotic fluids in early human pregnancy. Am J Obstet Gynecol 170:1365-1369.
36. Jauniaux E, Greenwold N, Hempstock J, Burton GJ. 2003. Comparison of ultrasonographic and Doppler mapping of the intervillous circulation in normal and abnormal early pregnancies. Fertil Steril 79:100-106.
37. Jin J, Yang J, Gao Z, Yu Y. 2004. Proteomic analysis of cellular responses to low concentration N-methyl-N′-nitro-N-nitrosoguanidine in human amnion FL cells. Environ Mol Mutagen 43: 93-99.
38. Kalinka J, Sobala W, Wasiela M, Brzezińska-Błaszczyk E. 2005. Decreased proinflammatory cytokines in cervicovaginal fluid, as measured in midgestation, are associated with preterm delivery. Am J Reprod Immunol 54:70-76.
39. Karty JA, Reilly JP. 2005. Deamidation as a consequence of beta-elimination of phosphopeptides. Anal Chem 77:4673-4676.
40. Kim YS, Kim MS, Lee SH, Choi BC, Lim JM, Cha KY, Baek KH. 2006. Proteomic analysis of recurrent spontaneous abortion: Identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics 6:3445-3454.
41. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR. 1996. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81:2742-2745.
42. Lee HC, Lee SW, Lee KW, Lee SW, Cha KY, Kim KH, Lee S. 2005. Identification of new proteins in follicular fluid from mature human follicles by direct sample rehydration method of two-dimensional polyacrylamide gel electrophoresis. J Korean Med Sci 20:456-460.
43. Liberatori S, Bini L, De Felice C, Magi B, Marzocchi B, Raggiaschi R, Frutiger S, Sanchez JC, Wilkins MR, Hughes G, Hochstrasser DF, Bracci R, Pallini V. 1997. A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation. Electrophoresis 18:2816-2822.
44. Liu AX, Zhu YM, Luo Q, Wu YT, Gao HJ, Zhu XM, Xu CM, Huang HF. 2007. Specific peptide patterns of follicular fluids at different growth stages analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Biochim Biophys Acta 1770:29-38.
45. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, Jones L, Deligdisch L, Garite TJ. 1991. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 5:669-674.
46. Lumley J. 2003. Defining the problem: The epidemiology of preterm birth. Br J Obstet Gynaecol 110:3-7.
47. Mavrou A, Anagnostopoulos AK, Kolialexi A, Vougas K, Papantoniou N, Antsaklis A, Fountoulakis M, Tsangaris GT. 2008. Proteomic analysis of amniotic fluid in pregnancies with turner syndrome fetuses. J Proteome Res 7:1862-1866.
48. Michaels JE, Dasari S, Pereira L, Reddy AP, Lapidus JA, Lu X, Jacob T, Thomas A, Rodland M, Roberts CT Jr, Gravett MG, Nagalla SR. 2007. Comprehensive proteomic analysis of the human amniotic fluid proteome: Gestational age-dependent changes. J Prot Res 6:1277-1285.
49. Magoffin DA, Jakimiuk AJ. 1997. Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women. Hum. Reprod 12:1714-1719.
50. Michel PE, Crettaz D, Morier P, Heller M, Gallot D, Tissot JD, Reymond F, Rossier JS. 2006. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 27:1169-1181.
51. Mitchell LM, Kennedy CR, Hartshorne GM. 2002. Effects of varying gonadotrophin dose and timing on antrum formation and ovulation efficiency of mouse follicles in vitro. Hum. Reprod 17:1181-1188.
52. Nagalla SR, Canick JA, Jacob T, Schneider KA, Reddy AP, Thomas A, Dasari S, Lu X, Lapidus JA, Lambert-Messerlian GM, Gravett MG, Roberts CT Jr, Luthy D, Malone FD, D'Alton ME. 2007. Proteomic analysis of maternal serum in down syndrome: Identification of novel protein biomarkers. J Proteome Res 6:1245-1257.
53. Nandi S, Kumar VG, Manjunatha BM, Gupta PS. 2007. Biochemical composition of ovine follicular fluid in relation to follicle size. Dev Growth Differ 49:61-66.
54. Nilsson S, Ramström M, Palmblad M, Axelsson O, Bergquist J. 2004. Explorative study of the protein composition of amniotic fluid by liquid chromatography electro-spray ionization Fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res 3:884-889.
55. Ogino M, Hiyamuta S, Takatsuji-Okawa M, Tomooka Y, Minoura S. 2005. Establishment of a prediction method for premature rupture of membranes in term pregnancy using active ceruloplasmin in cervicovaginal secretion as a clinical marker. J Obstet Gynaecol Res 31:421-426.
56. Oh JE, Fountoulakis M, Juranville JF, Rosner M, Hengstschläger M, Lubec G. 2004. Proteomic determination of metabolic enzymes of the amnion cell: Basis for a possible diagnostic tool? Proteomics 4:1145-1158.
57. Orczyk-Pawilowicz M, Florianski J, Zalewski J, Katnik-Prastowska I. 2005. Relative amounts of sialic acid and fucose of amniotic fluid glycoconjugates in relation to pregnancy age. Glycoconj J 22:433-442.
58. Page NM, Kemp CF, Butlin DJ, Lowry PJ. 2002. Placental peptides as markers of gestational disease. Reproduction 123:487-494.
59. Park SJ, Yoon WG, Song JS, Jung HS, Kim CJ, Oh SY, Yoon BH, Jung G, Kim HJ, Nirasawa T. 2006. Proteome analysis of human amnion and amniotic fluid by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proteomics 6:349-363.
60. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J, Simón C, 1999. The pathogenesis of ovarian hyperstimulation syndrome: In vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertil Steril 71:482-489.
61. Pereira L, Reddy AP, Jacob T, Thomas A, Schneider KA, Dasari S, Lapidus JA, Lu X, Rodland M, Roberts CT Jr, Gravett MG, Nagalla SR. 2007. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 6:1269-1276.
62. Qiao J, Yeung WS, Yao YQ, Ho PC. 1998. The effects of follicular fluid from patients with different indications for IVF treatment on the binding of human spermatozoa to the zona pellucida. Hum Reprod 13:128-131.
63. Queloz PA, Crettaz D, Thadikkaran L, Sapin V, Gallot D, Jani J, Deprest J, Lémery D, Barelli S, Tissot JD. 2006. Proteomic analyses of amniotic fluid: Potential applications in health and diseases. J Chromatogr B Analyt Technol. Biomed Life Sci 850:336-342.
64. Robinson NE, Robinson AB. 2001. Deamidation of human proteins. Proc Natl Acad Sci USA 98:12409-12413.
65. Robinson NE, Lampi KJ, McIver RT, Williams RH, Muster WC, Kruppa G, Robinson AB. 2005. Quantitative measurement of deamidation in lens betaB2-crystallin and peptides by direct electrospray injection and fragmentation in a Fourier transform mass spectrometer. Mol Vis 28:1211-1219.
66. Robinson NE, Zabrouskov V, Zhang J, Lampi KJ, Robinson AB. 2006. Measurement of deamidation of intact proteins by isotopic envelope and mass defect with ion cyclotron resonance Fourier transform mass spectrometry. Rapid Commun Mass Spectrom. 20:3535-3541.
67. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanas-siadis AP, Hobbins JC. 1989. Infection and labor. V. Prevalence, micro-biology, and clinical significance of intraamniotic infection in women with pre-term labor and intact membranes. Am J Obstet Gynecol 161:817-824.
68. Rüetschi U, Rosén A, Karlsson G, Zetterberg H, Rymo L, Hagberg H, Jacobsson B. 2005. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res 4:2236-2242.
69. Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, Kimura T. 2000. Cytokine production in chorioamnionitis. J Reprod Immunol 47:185-196.
70. Salustri A, Yanagishita M, Underhill CB, Laurent TC, Hascall VC. 1992. Localization and synthesis of hyaluronic acid in the cumulus cells and mural granulosa cells of the preovulatory follicle. Dev Biol 151:541-551.
71. Schweigert FJ, Gericke B, Wolfram W, Kaisers U, Dudenhausen JW. 2006. Peptide and protein profiles in serum and follicular fluid of women undergoing IVF. Hum Reprod 21:2960-2968.
72. Shankar R, Cullinane F, Brennecke SP, Moses EK. 2004. Applications of proteomic methodologies to human pregnancy research: A growing gestation approaching delivery? Proteomics 4:1909-1917.
73. Shaw JL, Smith CR, Diamandis EP. 2007. Proteomic analysis of human cervico-vaginal fluid. J Proteome Res 6:2859-2865.
74. Swamy GK, Simhan HN, Gammill HS, Heine RP. 2005. Clinical utility of fetal fibronectin for predicting preterm birth. J Reprod Med 50:851-856.
75. Tang LJ, De Seta F, Odreman F, Venge P, Piva C, Guaschino S, Garcia RC. 2007. Proteomic analysis of human cervical-vaginal fluids. J Proteome Res 6:2874-2983.
76. Thadikkaran L, Crettaz D, Siegenthaler MA, Gallot D, Sapin V, Iozzo RV, Queloz PA, Schneider P, Tissot JD. 2005. The role of proteomics in the assessment of premature rupture of fetal membranes. Clin Chim. Acta 360:27-36.
77. Tsangaris G, Weitzdörfer R, Pollak D, Lubec G, Fountoulakis M. 2005. The amniotic fluid cell proteome. Electrophoresis 26:1168-1173.
78. Tsangaris GT, Kolialexi A, Karamessinis PM, Anagnostopoulos AK, Antsaklis A, Fountoulakis M, Mavrou A. 2006a. The normal human amniotic fluid supernatant proteome. In Vivo 20:479-490.
79. Tsangaris GT, Karamessinis P, Kolialexi A, Garbis SD, Antsaklis A, Mavrou A, Foun-toulakis M. 2006b. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6:4410-4419.
80. Vascotto C, Salzano AM, D'Ambrosio C, Fruscalzo A, Marchesoni D, di Loreto C, Scaloni A, Tell G, Quadrifoglio F. 2007. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res 6:160-170.
81. Vesce F, Pavan B, Lunghi L, Giovannini G, Scapoli C, Piffanelli A, Biondi C. 2004. Inhibition of amniotic interleukin-6 and prostaglandin E2 release by ampicillin. Obstet Gynecol 103:108-113.
82. Vuadens F, Benay C, Crettaz D, Gallot D, Sapin V, Schneider P, Bienvenut WV, Lémery D, Quadroni M, Dastugue B, Tissot JD. 2003. Identification of biologic markers of the premature rupture of fetal membranes: Proteomic approach. Proteomics 3:1521-1525.
83. Wang TH, Chang YL, Peng HH, Wang ST, Lu HW, Teng SH, Chang SD, Wang HS. 2005. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat Diagn 25:559-566.
84. Welt CR, Smith ZA, Pauler DK, Hall JE. 2001. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J Clin Endocrinol. Metab 86:2531-2537.
85. WHO. 1987. The hypertensive disorders of pregnancy. In: World Health Organization Technical Report Series, 758. Geneva: World Health Organization.
86. Wunder DM, Kretschmer R, Bersinger NA. 2005. Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles. Hum Reprod 20:1266-1271.
87. Yao YQ, Yeung WS, Ho PC. 1996. Human follicular fluid inhibits the binding of human spermatozoa to zona pellucida in vitro. Hum Reprod 11:2674-2680.
88. Yeung WS, Lee KF, Koistinen R, Koistinen H, Seppala M, Ho PC, Chiu PC. 2006. Roles of glycodelin in modulating sperm function. Mol Cell Endocrinol 16:149-156.